Pfizer

Delhi CM Arvind Kejriwal on May 26 announced the supply of Sputnik V vaccine, but the quantity to be supplied remains uncertain. Introducing Delhi's first drive-through vaccination centre in Dwarka, CM Kejriwal also emphasized the effectiveness of Pfizer and Moderna vaccines in kids. The drive-through vaccination centre will be established at Chhatrasal on May 28. The state might go for unlock process after May 31 if COVID-19 cases start… read-more

A study conducted in England and Wales revealed that 96.42% of people administered with first COVID jab developed antibodies in 28-34 days. The study was conducted on 8,517 people who were administered with Pfizer or Astra-Zeneca (Covishield) vaccine. Whereas, in people administered with the second dose it was found that 99.08% of them have progressed antibodies in 7-14 days. The University College London researchers claimed effective of both… read-more

Oxford-AstraZeneca COVID-19 vaccine has shown 76% efficacy in its recent trials, claimed the pharmaceutical giant on March 25. The trial data came a week after the US health officials accused AstraZeneca of using "outdated information". Approved in over 70 countries, the vaccine was recently tested on 32,449 people in the US, Peru, and Chile, claiming 85% efficacy in people above 65. Notably, the other two US-made vaccines, Pfizer/BioNTech… read-more

Slamming reports criticizing Bharat Biotech's Covaxin, Chairman of the company Dr Krishna Ella stated the vaccine is nowhere inferior to Pfizer’s COVID-19 vaccine. In the press conference addressed by Dr Ella on January 4, he expressed his anger over people for "gossiping" and backlashing Indian companies. Speaking on transparency, he said that more than 70 articles had been published and Bharat Biotech conducted trials in over 12 countries… read-more

Amidst the fear of a new COVID-19 strain spreading in the UK, BioNTech CEO Ugur Sahin said that the company has "Scientific confidence" that Pfizer vaccine will work against the new variant as well. However, the efficacy can be confirmed only after studies, he added. Moreover, the company is ready to make changes in the vaccine to tackle the new strain of COVID-19, subject to the approval by the regulators.